Brief: HCW Biologics Exercised Right To Terminate Credit Agreement With Prime Capital Ventures

Hcw Biologics

12/01/2024 13:13

Jan 12 (Reuters) - HCW Biologics Inc  HCWB.O :
    * HCW BIOLOGICS INC: ON JAN 10, EXERCISED RIGHT TO TERMINATE
CREDIT AGREEMENT DATED APRIL 21, 2023, WITH PRIME CAPITAL
VENTURES, LLC
    * HCW BIOLOGICS INC - IS CURRENTLY SEEKING AN ALTERNATIVE
SOURCE
OF FINANCING TO ALLOW THE BUILDING PROJECT TO CONTINUE WITH
MINIMAL DELAYS
    * HCW BIOLOGICS INC - TERMINATION FOLLOWED REPEATED DELAYS
IN
FUNDING AND RELATED CONCERNS
    * HCW BIOLOGICS- ENTERED AGREEMENT TO OBTAIN FINANCING FOR
PURPOSE
OF BUILDING PROPOSED MANUFACTURING FACILITY AT NEW HEADQUARTERS
LOCATED IN MIRAMAR

Source text for Eikon:  ID: 
Further company coverage:  HCWB.O 

 ((Reuters.Briefs@thomsonreuters.com;))